Philip Morris International stock
PMNYSEPhilip Morris International Inc., Consumer DefensiveISIN US7181721090
75Score 75 out of 100, Strong
Price and trend
74 / 100
Price history
+25% in one yearThe chart shows daily closes over 19 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 7.3% above it.
Since February 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 43).
The price is 7.1% below its 52-week high. Largest decline in 19 years: 51% (June 2017 to March 2020).
Chart figures for advanced users
- SMA 50$195.87
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$183.04
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)43
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$147.81
- The lowest closing price of the last twelve months.
- Resistance$211.28
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Philip Morris International Inc. belongs to the Tobacco industry (United States) and, with a market value of $306.03B, is the largest of 15 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $40.65B (up 7.3% year on year) and earnings of $11.35B (up 61.3%).
- For fiscal 2026, analysts expect on average revenue of $43.57B (up 7.2%) and adjusted earnings per share of $8.35 (up 10.7%).
Show more
- MEQIRI Score 75 out of 100 (Strong): rank 28 of 295 in Consumer Defensive, median 62.
- The P/E is 28.7 (Tobacco median 15.7, own median of recent years 18.6).
- Our model puts fair value at $149.61, with the price 31% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- High return on capitalReturn on invested capital 35.8% in fiscal 2025, Tobacco median 11.5%.Profitability 96
- Reliable dividendNo dividend cut for 18 years.Capital allocation 78
- High marginNet margin 24.8% over the last 12 months, Tobacco median 11.7%.Profitability 96
Weaknesses
- Richly valuedP/E 28.7, Tobacco median 15.7, own median 18.6.Valuation 37
Its standout strengths are fundamentals and profitability, while valuation holds the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 73 to 75.
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk low
How well MEQIRI warnsOne of the 30% with the lowest crash risk among the 100 largest stocks.
From 2016 to 2025, 4 in 100 such stocks fell 30% or more within a year, against a group average of 9 in 100.
What lowers it
- solid fundamentals
- very large company
Valuation
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $115.09 and expensive above $213.73 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $191.81 (cash-flow model) and $107.41 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $133.40, at 7.8% it would be $173.94.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (15.7).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 7.9% on the twelve months before. Revenue has grown solidly since 2006, at about 4% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 67%, operating 37%, net 28%.
Debt & balance sheet
latest quarterMeaningfully leveraged, but the interest bill is comfortably covered.
Earnings
- Next earnings
- 5 Feb 2027in 85 days
- Last reported
- 21 Oct 2026EPS reported $2.36 (expected $2.30)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $8.35−0.6%
- Revenue
- $43.57B0.0%
- Earnings per share
- $9.06−1.1%
- Revenue
- $45.69B−0.5%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +1.6%2026 cigarette volume decline now expected at 2% to 3% versus 3% previously, with total shipment volume stable to slightly positive, while higher SG&A costs are expected in the second half.
“Given our Q2 performance and the latest industry dynamics, we now expect a more moderate full-year decline in our cigarette volumes of around 2%-3%, versus 3% previously, which remains consistent with the structural evolution of the category.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 22 Jul 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Philip Morris International
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
295 rated companies in Consumer Defensive
- This company
- 75
- Sector median
- 62
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Tobacco
The next smaller companies by market value
- British American Tobacco p.l.c.BTI $131.35B62
- Altria GroupMO $128.73B77
- Japan Tobacco2914.T $62.02B71
- ITCITC.NS $38.12B75
- Imperial BrandsITB.DE $28.99B68
- KT&G033780.KS $13.44B65
- Smoore International Holdings6969.HK $6.64B45
- RLX TechnologyRLX $1.88B53
ETFs that hold Philip Morris International
Held by 79 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR S&P U.S. Consumer Staples Select Sector UCITS ETF (Acc)ZPDS | 9.81% | 0.15% | €342.88M |
| Xtrackers MSCI USA Consumer Staples UCITS ETF 1DXUCS | 9.59% | 0.12% | €107.01M |
| iShares S&P 500 Consumer Staples Sector UCITS ETF2B7D | 9.39% | 0.15% | €518.36M |
Show 5 more
| Xtrackers MSCI World Consumer Staples UCITS ETF 1CXDWS | 6.11% | 0.25% | €965.83M |
| Xtrackers MSCI North America High Dividend Yield UCITS ETF 1CXDND | 2.17% | 0.39% | €264.04M |
| iShares Edge S&P 500 Minimum Volatility UCITS ETFIBCK | 1.58% | 0.20% | €1.97B |
| Franklin U.S. Equity UCITS ETFFLXU | 1.48% | 0.20% | €55.89M |
| iShares Dow Jones U.S. Select Dividend UCITS ETF (DE)EXX5 | 1.19% | 0.31% | €415.03M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 10 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.